What one share of Mediwound holds
We are a global leader in next-generation enzymatic therapeutics focused on non-surgical tissue repair. Our solutions selectively remove non-viable hazardous tissue while preserving healthy tissue, offering a safer and more effective alternative to traditional methods.
Mediwound’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2025-12-31; the balance sheet is as of 2025-12-31.
| Sales | $1.49 |
|---|---|
| Profit | −$2.10 |
| Capex (buildings and equipment) | $0.48 |
| Free cash flow | −$1.90 |
| Cash and investments | $0.37 |
| Book value | $3.40 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2021 | $6.11 | −$3.48 | $0.13 | −$2.42 | — | −$1.18 |
| 2022 | $5.31 | −$3.93 | $0.11 | −$2.49 | — | $1.51 |
| 2023 | $2.07 | −$0.75 | $0.72 | −$1.88 | — | $3.43 |
| 2024 | $2.03 | −$3.03 | $0.63 | −$2.00 | — | $2.89 |
| 2025 | $1.49 | −$2.10 | $0.48 | −$1.90 | — | $3.40 |
Common questions about Mediwound
How much does one share of Mediwound earn?
Over its latest fiscal year, Mediwound lost $2.10 for each share on $1.49 of sales.
Does Mediwound pay a dividend?
Mediwound didn’t pay a dividend over its latest fiscal year, according to its SEC filings.
What is Mediwound’s book value per share?
Mediwound’s book value is $3.40 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of December 31, 2025.
How much cash and debt does each share of Mediwound have?
Each share of Mediwound has $0.37 of cash and investments, as of December 31, 2025.
What is Mediwound’s free cash flow per share?
−$1.90 per share over its latest fiscal year. Free cash flow is the cash left over after spending on buildings and equipment.
Has Mediwound bought back shares?
Mediwound’s share count rose about 192% from 2021 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.